Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets
19th August 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Tag : USFDA
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream
18th August 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Bengaluru, – 09 August, 2025 : Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
28 July, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection
30th June, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg
15 May, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Tablets USP, 200 mg
17th April, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast
Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
20th December, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited’ Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav.
9th October, 2024, Bengaluru: Alembic Pharmaceuticals today announced that it has successfully completed the United States Food...